Anixa ovarian cancer CAR-T trial advances to fifth dose cohort

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Anixa ovarian cancer CAR-T trial advances to fifth dose cohort
(NASDAQ: ANIX) Delayed: 2.77 +0.01 (0.36%)
Previous Close $2.76    52 Week High $ 
Open $2.78    52 Week Low $ 
Day High $2.79    P/E N/A 
Day Low $2.69    EPS $ 
Volume 315,203